This thread is for investors or those who are interested in CDSL as an investment. Often the central reason quoted for an investment here is the gush of FCF the business produces and some float money also to boot. But this argument ignores a central problem as well. (1/11)

I completely agree that CDSL is a business that produces ample amount of Free Cash. So, it begs the question: "What are they doing with all that cash?" Generally, firms can utilize the cash on their books in 4 ways: Dividends, Acquisitions, Capex/Investments and Buybacks. (2/11)
CDSL does have a Dividend Payout Ratio of ~35-40%. But Dividends are the least efficient way of utilizing cash, due to the Triple Taxation on Dividends. More here:

https://t.co/DZCmOJ0TFi

(3/11)
Handled well, Inorganic Growth is so lucrative that some companies build their business models around acquisitions (Say, MSSL or Cyient). However, CDSL literally CAN'T be one such company. Read 7 (c) of the below regulatory document to know more:

https://t.co/071lwnnwJ4

(4/11)
CDSL can also reinvest cash into their own business, like most companies do. But CDSL (And most Exchanges) have little need for Capex/Reinvestment. CDSL's IPO came in at Rs. 523.99 Crores. Two years in, the Cash and Investments on their books stands at Rs. 650 Crores. (5/11)
In comparison, their Non-Financial Fixed Assets are only Rs. 75 Crores. Most of their cash sits in Debt instruments and Debt MFs. If this is the case, isn't it better to let the shareholders decide what securities they'd rather invest in? (i.e. Pay Dividends instead) (6/11)
That leaves us with Buybacks. If CDSL does a buyback, BSE's stake in CDSL will increase, which cannot cross 24%. Read 2 Para, Page 11 to know more:

https://t.co/ss1bYu5qGM

The recently introduced Buyback Tax is also a bummer, no doubt. (7/11)
If BSE agrees to dilute its stake in CDSL in a periodic manner, CDSL can do Buybacks at the right prices in the future. But this means that BSE shareholders lose out on all that value creation. So, this is an unlikely event too. (8/11)
In conclusion, CDSL IS a cashflow machine, but the uses of the cash are severely restricted. The best way to create shareholder value seems to be Dividends, which is ironically the LEAST efficient way to utilize cash for most firms. (9/11)
If your investment thesis for CDSL is anything other than a slow-to-moderate grower, with stable Margins and a buttload of Dividends, then you need to wake up and smell the salt. (10/11)
ANY investment can be great, when the right price is paid. If you'd like to know my opinion on how much CDSL is worth, visit the blog post below. I discuss the above points and more, converting the theory into numbers used in a Valuation model:

https://t.co/nhcpvkllMS

(11/11)

More from Dinesh Sairam

More from Ideas

You May Also Like

1/ Some initial thoughts on personal moats:

Like company moats, your personal moat should be a competitive advantage that is not only durable—it should also compound over time.

Characteristics of a personal moat below:


2/ Like a company moat, you want to build career capital while you sleep.

As Andrew Chen noted:


3/ You don’t want to build a competitive advantage that is fleeting or that will get commoditized

Things that might get commoditized over time (some longer than


4/ Before the arrival of recorded music, what used to be scarce was the actual music itself — required an in-person artist.

After recorded music, the music itself became abundant and what became scarce was curation, distribution, and self space.

5/ Similarly, in careers, what used to be (more) scarce were things like ideas, money, and exclusive relationships.

In the internet economy, what has become scarce are things like specific knowledge, rare & valuable skills, and great reputations.
@franciscodeasis https://t.co/OuQaBRFPu7
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the


chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project

starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".

P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!

https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?